Novartis Bets Big On Next-Gen Gene Therapy With Voyager Pact

Pays $54m Upfront To Access Capsids For Brain Diseases

 
• By Kevin Grogan
  
Adeno-associated virus serotype 1. Virus is used as a vector for gene therapy
Novartis keen on Voyager's novel AAV capsids • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies